Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

For decades, the accepted explanation for the origins of the Japanese people was relatively straightforward. Modern Japanese ...

Genomic testing based on chromosome microarray (CMA) and Next Generation Sequencing (NGS) revolutionized clinical genetics. That said, microarray, targeted panel, exome and generic whole genome ...

U.S. Genomic Medicine Market was valued at USD 9.93 billion in 2025 and is expected to reach USD 32.9 billion by 2035 owing to the increasing use of personalized medicineAustin, May 14, 2026 (GLOBE ...

Key opportunities lie in reagents & consumables due to their high usage, drug discovery's large market share, and significant growth in the U.S. market Gene Expression Analysis Market Gene Expression ...

Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, precision-led process, thanks to antenatal genomics.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy ...

Illumina () has held its Q1 earnings call. Read on for the main highlights of the call. Meet Samuel – Your Personal Investing Prophet. Start a conversation with TipRanks’ trus ...

Illumina () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smart ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed ...

Global NICU Genetic Testing Market OverviewThe global NICU Genetic Testing Market is projected to grow at a CAGR of ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...